EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Expanding the Psoriasis Framework: Immunopathogenesis and Treatment Updates

Yvonne Nong, George Han, Jason E Hawkes

Cutis · 2024

DOI: 10.12788/cutis.0949 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cutis, 2024. Verfasst von Yvonne Nong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Nong is from the Department of Internal Medicine, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Nong also is from and Dr. Hawkes is from…. Hauptthemen laut MEDLINE: Interleukin-17, Psoriasis. Die Arbeit wurde bisher 9-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic heterogeneous condition with multiple available treatment options that have resulted in dramatic disease improvements for patients. IL-23/IL-17 signaling is the central immune signaling pathway driving psoriasis, though recent research has uncovered other key contributing signals such as IL-17C, IL-17F, IL-36, and tyrosine kinase 2 (TYK2). Novel therapeutic targets inhibiting these cytokines have expanded our understanding of the pathogenesis of psoriasis. IL-23/IL-17 signaling is critical for the development of epidermal hyperplasia and the mature psoriatic plaque in susceptible individuals. Increased IL-17 and IL-23 expression works synergistically with other cytokines, such as IL-12, IL-22, IL-36, tumor necrosis factor (TNF), and interferon (IFN), to help create a self-sustaining, feed-forward circuit in keratinocytes, which contributes to the chronicity of the disease. This clinical review highlights recent discoveries in the immunopathogenesis of psoriasis and summarizes new antipsoriasis therapies targeting IL-36, IL-17F, aryl hydrocarbon receptors (AHRs), phosphodiesterase 4 (PDE4), and TYK2 signaling. Despite recent success in the treatment of psoriasis, continued research is needed to further advance disease understanding and shape management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-17PsoriasisHumansKeratinocytesCytokinesInterleukin-23

Substanzen

Interleukin-17CytokinesInterleukin-23

Autor:innen und Institutionen

  • Dr. Nong is from the Department of Internal Medicine, SUNY Downstate Medical Center, Brooklyn, New York. Dr. Nong also is from and Dr. Hawkes is from Integrative Skin Science and Research, Pacific Skin Institute, Sacram…

Zitieren

APA

Nong, Y., Han, G., & Hawkes, J. E. (2024). Expanding the Psoriasis Framework: Immunopathogenesis and Treatment Updates. Cutis. https://doi.org/10.12788/cutis.0949

Vancouver

Nong Y, Han G, Hawkes JE. Expanding the Psoriasis Framework: Immunopathogenesis and Treatment Updates. Cutis. 2024. doi:10.12788/cutis.0949

BibTeX
@article{Nong2024,
  author = {Nong, Yvonne and Han, George and Hawkes, Jason E},
  title = {Expanding the Psoriasis Framework: Immunopathogenesis and Treatment Updates},
  journal = {Cutis},
  year = {2024},
  doi = {10.12788/cutis.0949}
}
Kostenlos starten →